These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 13414977

  • 1. Complications of chlorpromazine and reserpine therapy.
    HUSSAR AE.
    GP; 1957 May; 15(5):85-93. PubMed ID: 13414977
    [No Abstract] [Full Text] [Related]

  • 2. [Extrapyramidal complications during treatment with chlorpromazine and reserpine: clinical and electromyographic study].
    Delay J, Deniker P, Bourguignon A, Lempérière T.
    Vertex; 2005 May; 16(64):469-72. PubMed ID: 16314902
    [No Abstract] [Full Text] [Related]

  • 3. [Oculogyric crises during successive treatment with reserpine & chlorpromazine].
    FREY B, MAUREL H, SPIELMANN JP.
    Ann Med Psychol (Paris); 1957 Mar; 115(3):515-9. PubMed ID: 13411735
    [No Abstract] [Full Text] [Related]

  • 4. [Contribution to the parkinsonian effects of chlorpromazine & reserpine].
    HASKOVEC L.
    Cas Lek Cesk; 1958 Jul 18; 97(30):932-8. PubMed ID: 13573425
    [No Abstract] [Full Text] [Related]

  • 5. Fatalities in patients receiving chlorpromazine and reserpine during 1956-1957 at Pilgrim State Hospital.
    ZLOTLOW M, PAGANINI AE.
    Am J Psychiatry; 1958 Aug 18; 115(2):154-6. PubMed ID: 13559513
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of parkinsonism-like syndromes caused by reserpine & chlorpromazine].
    KNAUF HW.
    Nervenarzt; 1958 Nov 20; 29(11):520-2. PubMed ID: 13622879
    [No Abstract] [Full Text] [Related]

  • 7. [Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
    BOURGUIGNON A, DELAY J, DENIKER P, LEMPERIERE T.
    Encephale; 1956 Nov 20; 45(4):1093-8. PubMed ID: 13384344
    [No Abstract] [Full Text] [Related]

  • 8. Breast changes in the male and female with chlorpromazine or reserpine therapy.
    ROBINSON B.
    Med J Aust; 1957 Aug 17; 44(7):239-41. PubMed ID: 13476931
    [No Abstract] [Full Text] [Related]

  • 9. [Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
    STECK H.
    Encephale; 1956 Aug 17; 45(4):1083-9. PubMed ID: 13384342
    [No Abstract] [Full Text] [Related]

  • 10. Untoward reactions to tranquilizing drugs.
    WARDELL DW.
    Am J Psychiatry; 1957 Feb 17; 113(8):745. PubMed ID: 13394752
    [No Abstract] [Full Text] [Related]

  • 11. [Systematic neuroleptic therapy with the appearance of parkinsonian states].
    FLUGEL F.
    Encephale; 1956 Feb 17; 45(4):1090-2. PubMed ID: 13384343
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Allergenicity of tranquilizing drugs.
    BERNSTEIN C, KLOTZ SD.
    J Am Med Assoc; 1957 Mar 16; 163(11):930-3. PubMed ID: 13405750
    [No Abstract] [Full Text] [Related]

  • 15. [Neuroleptics and the incidence of embolisms of the pulmonary artery according to the autopsy material].
    Borowicz A, Kostkowski A, Lisińska M, Nowak J.
    Neurol Neurochir Psychiatr Pol; 1965 Mar 16; 15(6):901-4. PubMed ID: 5864785
    [No Abstract] [Full Text] [Related]

  • 16. Management of the side effect of reserpine and combined reserpine-chlorpromazine treatment.
    BARSA J, GOSLINE E, KLINE NS.
    Dis Nerv Syst; 1956 Nov 16; 17(11):352-8. PubMed ID: 13365522
    [No Abstract] [Full Text] [Related]

  • 17. Harmine antagonism of drug-induced extra-pyramidal disturbances.
    Blum B, Weizmann H, Simpson GM, Krasilowsky D, Kulcsar IS, Merskey H.
    Psychopharmacologia; 1964 Oct 14; 6(4):307-10. PubMed ID: 5318866
    [No Abstract] [Full Text] [Related]

  • 18. [Therapeutic value of extra-pyramidal symptoms in chlorpromazine & reserpine therapy].
    HAASE HJ.
    Encephale; 1958 Oct 14; 47(6):519-32. PubMed ID: 13619545
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of anaphylactic death in the mouse toxicity prevention test for TRIC agents.
    Alexander ER, Fresh JW.
    Am J Ophthalmol; 1967 May 14; 63(5):Suppl:1462-9. PubMed ID: 6025172
    [No Abstract] [Full Text] [Related]

  • 20. [Complications following chlorpromazine and reserpine therapy of psychoses in the light of autopsy findings].
    ALBRETSEN CS.
    Nor Tannlaegeforen Tid; 1960 Sep 15; 80():870-1. PubMed ID: 13682170
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.